Posted on 11/9/20
Why Emergent BioSolutions Slipped on Friday
What happenedShareholders of vaccine and antibody therapy specialist Emergent BioSolutions (NYSE:EBS) were feeling a bit queasy on Friday afternoon. That day, the company's stock fell by . . .
Posted on 11/9/20
Moderna and Pfizer: A Tale of Two mRNA Coronavirus Vaccine Stocks
Ten programs are currently involved in phase 3 trials. But Moderna and Pfizer are arguably the closest to earning Emergency Use Authorizations (EUAs) for their vaccine . . .
Posted on 11/9/20
3 Red Flags for Inovio Pharmaceuticals' Future
In the early days of the coronavirus pandemic, Inovio Pharmaceuticals (NASDAQ:INO) was an exciting frontrunner in the vaccine race. The company garnered attention after it claimed . . .
Posted on 11/9/20
Moderna and Pfizer: A Tale of Two mRNA Coronavirus Vaccine Stocks
Ten programs are currently involved in phase 3 trials. But Moderna and Pfizer are arguably the closest to earning Emergency Use Authorizations (EUAs) for their vaccine . . .
Posted on 11/9/20
Here's Why Vertex Pharmaceuticals Fell 23.4% in October
What happenedShares of Vertex Pharmaceuticals (NASDAQ:VRTX) fell 23.4% in October, according to data from S&P Global Market Intelligence after the biotech discontinued development of a drug . . .
Posted on 11/8/20
Howard County General Hospital Offers Community COVID-19 Testing
Howard County General Hospital will offer community COVID-19 testing for children and adults in November and December at no cost to participants. Tests will be administered . . .
Posted on 11/8/20
Children’s Diagnostic & Treatment Center Launches Bee Healthy Wellness Program
Helena Gaviria, M.D., Unhealthy eating habits, boredom, depression and less physical activity than normal, combined with extra screen time, have led to a dangerous weight gain . . .
Posted on 11/8/20
Dr. Joel Buchalter Named Director of Joint Replacement Surgery at Northern Westchester Hospital’s Orthopedic and Spine Institute
Joel S. Buchalter, MD, FAAOS, FACS, an orthopedic surgeon with more than three decades of experience
Posted on 11/6/20
FDA Grants Emergency Use Authorization for Proprietary Mask from HanesBrands
The U.S. Food and Drug Administration issued an emergency use authorization for a proprietary mask developed by HanesBrands along with researchers from the University of North . . .
Posted on 11/6/20
CVS Health Reports Third Quarter Results
CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended September 30, 2020.CVS Health President and CEO Larry J. Merlo stated, "Our . . .
Posted on 11/6/20
MEDNAX Reports Third Quarter Results
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in prenatal, neonatal, and pediatric services, today reported a net loss of $41.0 . . .
Posted on 11/6/20
Epizyme Reports Business Progress and Third Quarter 2020 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today provided business and portfolio updates and reported third . . .
Posted on 11/6/20
GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2020
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC) today reported its financial results for the third quarter ended September 30, 2020, and highlighted recent company events. Cash and . . .
Posted on 11/6/20
SCYNEXIS Reports Third Quarter 2020 Financial Results and Provides Company Update
JERSEY CITY, N.J., Nov. 06, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to potentially overcome and prevent difficult-to-treat and . . .
Posted on 11/6/20
Genesis Healthcare to Release Third Quarter 2020 Results and Provide COVID-19 Update
KENNETT SQUARE, Pa., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE:GEN), one of the nation’s largest providers of post-acute care, today announced that it expects . . .
Posted on 11/6/20
Ocugen Provides Business Update and Third Quarter 2020 Financial Results
MALVERN, Pa., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to cure blindness . . .
Posted on 11/6/20
Matinas BioPharma Reports Third Quarter 2020 Financial Results and Operational Highlights
BEDMINSTER, N.J., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on developing next generation therapeutics to . . .
Posted on 11/6/20
Jounce Therapeutics Reports Third Quarter 2020 Financial Results
CAMBRIDGE, Mass., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies . . .
Posted on 11/6/20
Epizyme Closes $150 Million Financing
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that the company has entered into an . . .
Posted on 11/6/20
Here's How Teradata Stock Fell 19% Last Month
What happenedShares of data analytics and database software maker Teradata (NYSE:TDC) fell 19.1% in October 2020, according to data from S&P Global Market Intelligence. When investors . . .
Posted on 11/6/20
Is Novavax About to Achieve Warp Speed in the Coronavirus Vaccine Race?
With 11 coronavirus vaccine candidates in phase 3 trials and 49 in earlier stages, it can be hard for laypeople to estimate which has the best . . .
Posted on 11/6/20
Merck Makes a $2.8 Billion Bet on an Experimental New Cancer Drug
One of America's largest pharmaceutical companies is about to get a little bigger. On Thursday, Merck (NYSE:MRK) agreed to acquire a privately held biotech start-up called . . .
Posted on 11/6/20
Biogen Changes The World And Grows 44%
SummaryBiogen had a dramatic day, after years of flip-flop, as it appears the company's new Aducanumab drug will be approved.Even outside of Aducanumab, the company has . . .
Posted on 11/6/20
Teladoc Health: A Quantitative Valuation
SummaryTeladoc Health is rapidly growing revenue and operates in a growing sector of the economy.Combining with Livongo Health gives the company access to a larger addressable . . .
Posted on 11/6/20
Is Teladoc Health a Buy on the Pullback?
Digital health was a struggling industry prior to the coronavirus pandemic, but COVID-19 changed the game, pushing consumers and providers alike toward digital health solutions. Unsurprisingly, . . .

